[HTML][HTML] Safety and efficacy of gene transfer for Leber's congenital amaurosis

…, X Zhu, B Hauck, O Zelenaia… - … England Journal of …, 2008 - Mass Medical Soc
<p id="p001">Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases
with onset during childhood. One form of the disease, LCA2, is caused by mutations in the …

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

…, S Banfi, DC Chung, JIW Morgan, B Hauck, O Zelenaia… - The Lancet, 2009 - thelancet.com
Background Gene therapy has the potential to reverse disease or prevent further deterioration
of vision in patients with incurable inherited retinal degeneration. We therefore did a …

[HTML][HTML] Hemophilia B gene therapy with a high-specific-activity factor IX variant

…, VR Arruda, JCM van der Loo, O Zelenaia… - … England Journal of …, 2017 - Mass Medical Soc
Background The prevention of bleeding with adequately sustained levels of clotting factor,
after a single therapeutic intervention and without the need for further medical intervention, …

Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons

…, M Munir, A Kalandadze, OA Zelenaia… - Molecular …, 1998 - ASPET
Sodium-dependent transport into astrocytes is critical for maintaining the extracellular
concentrations of glutamate below toxic levels in the central nervous system. In this study, the …

[HTML][HTML] Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer

…, A Komaromy, JB Jacobs, B Hauck, O Zelenaia… - Molecular Therapy, 2008 - cell.com
We evaluated the safety and efficacy of an optimized adeno-associated virus (AAV; AAV2.RPE65)
in animal models of the RPE65 form of Leber congenital amaurosis (LCA). Protein …

Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3 …

O Zelenaia, BD Schlag, GE Gochenauer, R Ganel… - Molecular …, 2000 - ASPET
The glial glutamate transporter GLT-1 may be the predominant Na + -dependent glutamate
transporter in forebrain. Expression of GLT-1 correlates with astrocyte maturation in vivo and …

Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material

…, B Van Montfort, G Veres, JF Wright, Y Xu, O Zelenaia… - 2010 - liebertpub.com
A recombinant adeno-associated virus serotype 2 Reference Standard Material (rAAV2 RSM)
has been produced and characterized with the purpose of providing a reference standard …

Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT‐1/EAAT2 subtype

LB Li, SV Toan, O Zelenaia, DJ Watson… - Journal of …, 2006 - Wiley Online Library
In the nervous system, astrocytes express different ratios of the two glial glutamate
transporters, glutamate transporter subtype 1 (GLT‐1) and glutamate/aspartate transporter (GLAST), …

[HTML][HTML] Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses

…, SL Murphy, PH Smith, G Qu, X Liu, O Zelenaia… - Molecular Therapy, 2009 - cell.com
In a gene therapy clinical trial for hemophilia B, adeno-associated virus 2 (AAV2) capsid–specific
CD8 + T cells were previously implicated in the elimination of vector-transduced …

[HTML][HTML] Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model

…, K Brady, SA Moschos, B Hauck, O Zelenaia… - Molecular Therapy, 2012 - cell.com
The hepatitis C virus (HCV) chronically infects 2% of the world population and effective
treatment is limited by long duration and significant side-effects. Here, we describe a novel drug, …